Next Article in Journal
The Agony of Choice—Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond
Next Article in Special Issue
The Antiviral Drug Efavirenz in Breast Cancer Stem Cell Therapy
Previous Article in Journal
Targeted Therapies and Druggable Genetic Anomalies in Acute Myeloid Leukemia: From Diagnostic Tools to Therapeutic Interventions
Previous Article in Special Issue
Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments
 
 
Review

Article Versions Notes

Cancers 2021, 13(18), 4699; https://doi.org/10.3390/cancers13184699
Action Date Notes Link
article xml file uploaded 19 September 2021 12:33 CEST Original file -
article xml uploaded. 19 September 2021 12:33 CEST Update -
article pdf uploaded. 19 September 2021 12:33 CEST Version of Record -
article xml file uploaded 19 September 2021 12:33 CEST Update -
article xml uploaded. 19 September 2021 12:33 CEST Update https://www.mdpi.com/2072-6694/13/18/4699/xml
article pdf uploaded. 19 September 2021 12:33 CEST Updated version of record https://www.mdpi.com/2072-6694/13/18/4699/pdf
article html file updated 19 September 2021 12:34 CEST Original file -
article html file updated 19 September 2021 12:35 CEST Update -
article html file updated 30 July 2022 06:41 CEST Update https://www.mdpi.com/2072-6694/13/18/4699/html
Back to TopTop